National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 7218 [2014-02457]
Download as PDF
<![CDATA[
7218
Federal Register / Vol. 79, No. 25 / Thursday, February 6, 2014 / Notices
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
6707 Democracy Boulevard, Room 959,
Bethesda, MD 20892, 301–451–3397,
sukharem@mail.nih.gov.
Dated: January 31, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–02458 Filed 2–5–14; 8:45 am]
BILLING CODE 4140–01–P
Contact Person: Robert Wellner, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 706, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, rw175w@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS).
Dated: January 31, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–02457 Filed 2–5–14; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Digestive Diseases and
Nutrition C Subcommittee.
Date: March 13–14, 2014.
Open: March 13, 2014, 8:00 a.m. to 8:30
a.m.
Agenda: To review policy and procedures.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Closed: March 13, 2014, 8:30 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Closed: March 14, 2014, 8:00 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
VerDate Mar<15>2010
18:18 Feb 05, 2014
Jkt 232001
National Institutes of Health
Report on Carcinogens Webinar on
Trichloroethylene; Notice of Public
Webinar and Registration Information
The National Toxicology
Program (NTP) announces a public
webinar, ‘‘Human Cancer Studies on
Exposure to Trichloroethylene (TCE):
Methods Used To Assess Exposure and
Cancer Outcomes.’’ The Office of the
Report on Carcinogens (ORoC), Division
of the NTP (DNTP), National Institute of
Environmental Health Sciences (NIEHS)
will hold the webinar using Adobe®
ConnectTM, and the public can register
to attend.
DATES:
Webinar: March 17, 2014, 9:00 a.m. to
approximately 1:00 p.m. Eastern
Daylight Time (EDT).
Registration for Webinar: February 6,
2014 through March 13, 2014.
Availability of Webinar Materials:
March 3, 2014.
ADDRESSES: Webinar Web page: https://
ntp.niehs.nih.gov/go/tcewebinar.
FOR FURTHER INFORMATION CONTACT: Dr.
Ruth M. Lunn, Director, ORoC, DNTP,
NIEHS, P.O. Box 12233, MD K2–14,
Research Triangle Park, NC 27709.
Phone: (919) 316–4637; Fax: (301) 480–
2970, Email: lunn@niehs.nih.gov. Hand
Delivery/Courier: 530 Davis Drive, Room
2138, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background: The Report on
Carcinogens (RoC) is a congressionally
mandated, science-based, public health
report that identifies agents, substances,
mixtures, or exposures (collectively
called ‘‘substances’’) in our environment
that are cancer hazards for people living
in the United States. The NTP prepares
the RoC on behalf of the Secretary of
SUMMARY:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Health and Human Services following
an established, four-part process (https://
ntp.niehs.nih.gov/go/rocprocess) and
using established criteria (https://ntp.
niehs.nih.gov/go/15209).
Trichloroethylene (TCE) is a
chlorinated alkene used primarily as a
metal degreaser and is currently listed
as reasonably anticipated to be a human
carcinogen in the RoC. The NTP
selected TCE for re-review for possible
change in listing status in the RoC
following solicitation of public
comment and review by the NTP Board
of Scientific Counselors on June 21–22,
2012 (https://ntp.niehs.nih.gov/go/9741)
(for more information on the status of
the NTP review of TCE see https://ntp.
niehs.nih.gov/go/37899).
The purpose of this webinar is (1) to
obtain external scientific input, focusing
on issues related to the assessment of
information (exposure and cancer
outcomes) in epidemiologic studies of
TCE, which will be used to inform the
NTP’s evaluation of the level of
evidence from human cancer studies of
TCE exposure, and (2) to obtain public
input on the protocol for preparation of
the draft RoC monograph on TCE. The
first part of the webinar will consist of
three presentations, with a short
question-and-answer period after each
presentation, followed by a general
discussion session on scientific issues
across all presentations. The goals of the
individual presentations are (1) to
address the adequacy of methods used
in the epidemiologic studies to assess
exposure and cancer outcomes
(primarily lymphohematopoietic
cancers), (2) to discuss and compare
reported or estimated exposure levels or
exposure prevalence across studies, (3)
to discuss how this information (e.g.,
data from TCE exposure assessments,
quality of exposure assessment, TCE
exposure levels or prevalence,
classification of non-Hodgkin
lymphoma) is used in the epidemiologic
studies and can be used to inform the
cancer evaluation across studies. The
second part of the webinar will be a
discussion session when the public can
either make comments on or ask
questions about the proposed protocol
for preparation of the draft RoC
monograph on TCE (https://ntp.niehs.
nih.gov/NTP/roc/thirteenth/Protocols/
TCE_Protocol12-31-13_508.pdf).
Webinar and Registration: The
webinar is scheduled for March 17,
2014, from 9:00 a.m. to approximately 1
p.m. EDT. The webinar may end early
if the presentations and discussions are
finished. Registration for the webinar is
required and is open from February 6,
2014 through March 13, 2014, at
https://ntp.niehs.nih.gov/go/pcpwebinar.
E:\FR\FM\06FEN1.SGM
06FEN1
]]>Agencies
[Federal Register Volume 79, Number 25 (Thursday, February 6, 2014)]
[Notices]
[Page 7218]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-02457]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group; Digestive Diseases and
Nutrition C Subcommittee.
Date: March 13-14, 2014.
Open: March 13, 2014, 8:00 a.m. to 8:30 a.m.
Agenda: To review policy and procedures.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Closed: March 13, 2014, 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Closed: March 14, 2014, 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Robert Wellner, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 706, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
rw175w@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS).
Dated: January 31, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-02457 Filed 2-5-14; 8:45 am]
BILLING CODE 4140-01-P
